Providing surgeons with an “off the shelf” bone graft substitute to aid in bone healing is advantageous providing the materials participate in and facilitate the desired goal of fusion. Synthetic calcium phosphate-based (CaP) materials are excellent candidates considering their comparable composition to bone mineral however other factors have been shown to play a role in osteogenic behavior of these materials including surface chemistry and surface topography. The preclinical rabbit posterolateral fusion developed by Professor Boden provides a robust means to evaluate the in vivo performance of graft materials in this challenging indication.
|Number of pages||1|
|Journal||The Spine Journal|
|Early online date||9 Sep 2020|
|Publication status||Published - Sep 2020|